Pharma's Almanac: Nice Insight's Content Community

ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Market Analysis

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Biotech Funding Ups and Downs

Nice Insight Reports

Biotech Funding Ups and Downs

April Stanley, MS MBA

Nice Insight

PAO-04-24-NI-01Apr 02, 2024

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

FDA New Drug Approvals

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-03-23-NI-03Mar 07, 2023

State of the Cell and Gene Therapy Market

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

PAO-10-022-NI-01Oct 11, 2022